Plain-English translation of NCT06357754 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
If you received a Bristol-Myers Squibb gene-modified cell therapy (such as or ) and have since been diagnosed with a new, separate cancer, this study may be right for you. Researchers want to test your tumor sample to measure levels of the modified cells from your original treatment. This helps them understand whether the therapy you received is connected to your new cancer diagnosis.
When patients receive gene-modified cell therapies and later develop a second cancer, it's important for doctors to understand if the therapy played a role. By testing tumor samples, researchers can gather information that helps keep future patients safe and informs treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will ask you to provide a sample of your tumor tissue (usually already collected during your cancer diagnosis) for laboratory testing. There are no ongoing visits or long-term commitments — this is primarily a one-time sample collection to help the research team analyze the therapy's connection to your new cancer. The testing is done in a laboratory and does not require you to take any medication or undergo additional procedures.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Germany